Effect of outpatient therapy with inhaled corticosteroids on decreasing in-hospital mortality from pneumonia in patients with COPD

References

• World Health Organization20 June 2013. The top 10 causes of death Available from: http://www.who.int/mediacentre/factsheets/fs310/en/Accessed March 14, 2014
   Google Scholar
• HoggJCChuFUtokaparchSThe nature of small-airway obstruction in chronic obstructive pulmonary diseaseN Engl J Med20043502645265315215480
   PubMed Web of Science ®Google Scholar
• VestboJHurdSSAgustiAGGlobal strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summaryAm J Respir Crit Care Med201318734736522878278
   PubMed Web of Science ®Google Scholar
• TashkinDPFabbriLMLong-acting beta-agonists in the management of chronic obstructive pulmonary disease: current and future agentsRespir Res20101114921034447
   PubMed Web of Science ®Google Scholar
• CalverleyPMAndersonJACelliBSalmeterol and fluticasone propionate and survival in chronic obstructive pulmonary diseaseN Engl J Med200735677578917314337
   PubMed Web of Science ®Google Scholar
• TashkinDPCelliBSennSA 4-year trial of tiotropium in chronic obstructive pulmonary diseaseN Engl J Med20083591543155418836213
   PubMed Web of Science ®Google Scholar
• SpencerSCalverleyPMBurgePSJonesPWImpact of preventing exacerbations on deterioration of health status in COPDEur Respir J20042369870215176682
   PubMed Web of Science ®Google Scholar
• SzafranskiWCukierARamirezAEfficacy and safety of budesonide/formoterol in the management of chronic obstructive pulmonary diseaseEur Respir J200321748112570112
   PubMed Web of Science ®Google Scholar
• PauwelsRALofdahlCGLaitinenLALong-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. European Respiratory Society Study on Chronic Obstructive Pulmonary DiseaseN Engl J Med19993401948195310379018
   PubMed Web of Science ®Google Scholar
• VestboJSorensenTLangePBrixATorrePViskumKLong-term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: a randomised controlled trialLancet19993531819182310359405
   PubMed Web of Science ®Google Scholar
• van NoordJAAumannJLJanssensEComparison of tiotropium once daily, formoterol twice daily and both combined once daily in patients with COPDEur Respir J20052621422216055868
   PubMed Web of Science ®Google Scholar
• TashkinDPPearleJIezzoniDVargheseSTFormoterol and tiotropium compared with tiotropium alone for treatment of COPDCOPD20096172519229704
   PubMedGoogle Scholar
• BatemanEDFergusonGTBarnesNDual bronchodilation with QVA149 versus single bronchodilator therapy: the SHINE studyEur Respir J2013421484149423722616
   PubMed Web of Science ®Google Scholar
• WedzichaJADecramerMFickerJHAnalysis of chronic obstructive pulmonary disease exacerbations with the dual bronchodilator QVA149 compared with glycopyrronium and tiotropium (SPARK): a randomised, double-blind, parallel-group studyLancet Respir Med2013119920924429126
   PubMed Web of Science ®Google Scholar
• MagnussenHDisseBRodriguez-RoisinRWithdrawal of inhaled glucocorticoids and exacerbations of COPDN Engl J Med20143711285129425196117
   PubMed Web of Science ®Google Scholar
• RestrepoMIMortensenEMPughJAAnzuetoACOPD is associated with increased mortality in patients with community-acquired pneumoniaEur Respir J20062834635116611653
   PubMed Web of Science ®Google Scholar
• HasegawaWYamauchiYYasunagaHFactors affecting mortality following emergency admission for chronic obstructive pulmonary diseaseBMC Pulm Med20141415125253449
   PubMed Web of Science ®Google Scholar
• ErnstPGonzalezAVBrassardPSuissaSInhaled corticosteroid use in chronic obstructive pulmonary disease and the risk of hospitalization for pneumoniaAm J Respir Crit Care Med200717616216617400730
   PubMed Web of Science ®Google Scholar
• JooMJAuDHFitzgibbonMLLeeTAInhaled corticosteroids and risk of pneumonia in newly diagnosed COPDRespir Med201010424625219879745
   PubMed Web of Science ®Google Scholar
• SuissaSPatenaudeVLapiFErnstPInhaled corticosteroids in COPD and the risk of serious pneumoniaThorax2013681029103624130228
   PubMed Web of Science ®Google Scholar
• SinghSAminAVLokeYKLong-term use of inhaled corticosteroids and the risk of pneumonia in chronic obstructive pulmonary disease: a meta-analysisArch Intern Med200916921922919204211
   PubMed Web of Science ®Google Scholar
• SinganayagamAChalmersJDAkramARHillATImpact of inhaled corticosteroid use on outcome in COPD patients admitted with pneumoniaEur Respir J201138364121429980
   PubMed Web of Science ®Google Scholar
• Malo de MolinaRMortensenEMRestrepoMICopelandLAPughMJAnzuetoAInhaled corticosteroid use is associated with lower mortality for subjects with COPD and hospitalised with pneumoniaEur Respir J20103675175720413535
   PubMed Web of Science ®Google Scholar
• ChenDRestrepoMIFineMJObservational study of inhaled corticosteroids on outcomes for COPD patients with pneumoniaAm J Respir Crit Care Med201118431231621512168
   PubMed Web of Science ®Google Scholar
• Hugh-JonesPLambertAVA simple standard exercise test and its use for measuring exertion dyspnoeaBMJ19521657114896031
   PubMed Web of Science ®Google Scholar
• YamauchiYYasunagaHMatsuiHComparison of clinical characteristics and outcomes between aspiration pneumonia and community-acquired pneumonia in patients with chronic obstructive pulmonary diseaseBMC Pulm Med2015156926152178
   PubMed Web of Science ®Google Scholar
• OhtaTWagaSHandaWSaitoITakeuchiKNew grading of level of disordered consciousness (author’s transl)No Shinkei Geka197426236274477641
   PubMedGoogle Scholar
• TodoTUsuiMTakakuraKTreatment of severe intraventricular hemorrhage by intraventricular infusion of urokinaseJ Neurosurg19917481861984512
   PubMed Web of Science ®Google Scholar
• MahoneyFIBarthelDWFunctional evaluation: the Barthel indexMd State Med J196514616514258950
   PubMedGoogle Scholar
• ShindoYSatoSMaruyamaEComparison of severity scoring systems A-DROP and CURB-65 for community-acquired pneumoniaRespirology20081373173518713094
   PubMed Web of Science ®Google Scholar
• BarnesPJNew anti-inflammatory targets for chronic obstructive pulmonary diseaseNat Rev Drug Discov20131254355923977698
   PubMed Web of Science ®Google Scholar
• KellumJAKongLFinkMPUnderstanding the inflammatory cytokine response in pneumonia and sepsis: results of the Genetic and Inflammatory Markers of Sepsis (GenIMS) StudyArch Intern Med20071671655166317698689
   PubMed Web of Science ®Google Scholar
• SellaresJLopez-GiraldoALucenaCInfluence of previous use of inhaled corticoids on the development of pleural effusion in community-acquired pneumoniaAm J Respir Crit Care Med20131871241124823590264
   PubMed Web of Science ®Google Scholar
• BarbierMAgustiAAlbertiSFluticasone propionate reduces bacterial airway epithelial invasionEur Respir J2008321283128818684852
   PubMed Web of Science ®Google Scholar
• BarnesPJAsthma-COPD overlapChest20161497826757281
   PubMed Web of Science ®Google Scholar
• HardinMSilvermanEKBarrRGCOPD Gene InvestigatorsThe clinical features of the overlap between COPD and asthmaRespir Res20111212721951550
   PubMed Web of Science ®Google Scholar
• MenezesAMMontes de OcaMPerez-PadillaRIncreased risk of exacerbation and hospitalization in subjects with an overlap phenotype: COPD-asthmaChest201414529730424114498
   PubMed Web of Science ®Google Scholar
• FuJJGibsonPGSimpsonJLMcDonaldVMLongitudinal changes in clinical outcomes in older patients with asthma, COPD and asthma-COPD overlap syndromeRespiration201487637424029561
   PubMed Web of Science ®Google Scholar
• YamauchiYYasunagaHMatsuiHComparison of in-hospital mortality in patients with COPD, asthma and asthma-COPD overlap exacerbationsRespirology20152094094625998444
   PubMed Web of Science ®Google Scholar
• AgustiACalverleyPMCelliBCharacterisation of COPD heterogeneity in the ECLIPSE cohortRespir Res20101112220831787
   PubMed Web of Science ®Google Scholar